Citation Impact

Citing Papers

Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Treatment of Refractory Mycobacterium avium Complex Lung Disease with a Moxifloxacin-Containing Regimen
2013
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999
2000
Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006
2010
Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda
2013
Glutaraldehyde: Current Status and Uses
1994
A Steady Increase in Nontuberculous Mycobacteriosis Mortality and Estimated Prevalence in Japan
2014
Long-term relapses after 12-month treatment forMycobacterium kansasiilung disease
2008
Treatment of pulmonary disease caused by Mycobacterium kansasii: Results of 18 vs 12 months' chemotherapy
1995
The success and failure of BCG — implications for a novel tuberculosis vaccine
2005
Variation in protection by BCG: implications of and for heterologous immunity
1995
Mycobacterium xenopi infection and aspergilloma
1988
Synergistic effects of antimycobacterial drag combinations onMycobacterium avium complex determined radiometrically in liquid medium
1987
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti
2002
Effects of ortho-phthalaldehyde, glutaraldehyde and chlorhexidine diacetate on Mycobacterium chelonae and Mycobacterium abscessus strains with modified permeability
2003
Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands
2009
Wearable biosensors for healthcare monitoring
2019 Standout
Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
2006
Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults
1999
Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria
1994
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
2012
Electrochemistry of Nanoparticles
2014
Advancing the Electrochemistry of the Hydrogen‐Evolution Reaction through Combining Experiment and Theory
2014 Standout
Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection
1988
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
2001
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
2010
Biological effects of ultrasound: Development of safety guidelines. Part II: General review
2001
Mitogen-activated protein kinase pathways
1997 Standout
Increasing Incidence of Mycobacterium xenopi at Bellevue Hospital
2000
Disseminated Infection with Mycobacterium gordonae: Report of a Case and Critical Review of the Literature
1992
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Mycobacterium malmoense Infections in the United States, January 1993 through June 1995
1998
Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children
1992
Epidemiology and Clinical Significance of Nontuberculous Mycobacteria in Patients Negative for Human Immunodeficiency Virus in Switzerland
1992
The therapeutic approach to non-tuberculous mycobacterial infection of the lung
2010
Nontuberculous Mycobacterial Disease in Northern Australia: A Case Series and Review of the Literature
2000
TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy
2019 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines
2019
Antibacterial activity of chlorhexidine
1993
Endoscopy: disinfectants and health
1994
Mechanisms of Bacterial Resistance to Antibiotics and Biocides
1998
Evidence that Antituberculosis Drugs Are Really Effective in the Treatment of Pulmonary Infection Caused by Mycobacterium avium Complex
1988
Mycobactericidal activity of selected disinfectants using a quantitative suspension test
1999
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999
2000
Clarithromycin in the Treatment of Mycobacterium avium Lung Infections in Patients Without AIDS
1995
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France
2008
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease
2011
Mycobacterial Lymphadenitis in Children: A Prospective Study of 105 Nontuberculous Cases with Long-Term Follow-Up
1995
Epidemiology of human pulmonary infection with mycobacteria nontuberculous
2002
Clinical and radiological features of Mycobacterium kansasii and other NTM infections
2012
Pulmonary infection due to Mycobacterium szulgai, case report and review of the literature
1998
Mycobacterium avium Complex Pulmonary Disease Presenting as an Isolated Lingular or Middle Lobe Pattern
1992
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
2015
Pleural aspergillosis in a 14 year old boy.
1987
Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans
2014 Standout
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
2015
Infection with Mycobacterium malmoense in Sweden: Report of 221 Cases
1994
Extrapulmonary and Disseminated Infections Due to Mycobacterium malmoense: Case Report and Review
1993
Pulmonary Infection due to <i>Mycobacterium szulgai</i>
2003
Clinical and Chest Radiographic Findings Among Persons With Sputum Culture Positive for Mycobacterium gordonae
2000
Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response
2004
Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy
2016 Standout
Endoscope decontamination: where do we go from here?
1995
Mycobacterium xenopi Pneumonia in the Southeastern United States
2003
In-use evaluation of Perasafe® compared with Cidex® in fibreoptic bronchoscope disinfection
2003
Leprosy
2004 Standout
Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak
2001
A Cluster of Cases ofMycobacterium szulgaiKeratitis That Occurred after Laser‐Assisted In Situ Keratomileusis
2002
Efficacy of selected disinfectants against Mycobacteria and Cryptosporidia
1994
Pulmonary Infection with Nontuberculous Mycobacteria
1988
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
Clinical relevance ofMycobacterium malmoenseisolation in the Netherlands
2009
Nontuberculous Mycobacterial Lung Infections in Ontario, Canada: Clinical and Microbiological Characteristics
2010
Tuberculosis
2003
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Distribution of Phthiocerol Diester, Phenolic Mycosides and Related Compounds in Mycobacteria
1988
Bacterial resistance to disinfectants: present knowledge and future problems
1999
Treatment of Multidrug-Resistant Tuberculosis
1993
Tuberculin Skin Testing and In Vitro T Cell Responses to ESAT‐6 and Culture Filtrate Protein 10 after Infection withMycobacterium marinumorM. kansasii
2002
Mycobacterium szulgai Infection of the Lung: Case Report and Review of an Unusual Pathogen
1997
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Cutaneous Mycobacterium Malmoense Infection in an Immunocompromised Patient
1990
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
In-vitro evaluation of Perasafe® compared with 2% alkaline glutaraldehyde against Mycobacterium spp.
2003
Multiple imputation using chained equations: Issues and guidance for practice
2010 Standout
Genome-Based Taxonomic Classification of the Phylum Actinobacteria
2018 Standout
Nontuberculous Pulmonary Mycobacteriosis in Denmark
2009
Silver nanoparticles as a new generation of antimicrobials
2008 Standout
Mycobacterium avium genotype is associated with the therapeutic response to lung infection
2013
Effect of Clarithromycin Regimen for Mycobacterium avium Complex Pulmonary Disease
1999
Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria
1990 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
1998
Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
2011
Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli
2007 Standout
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Operational Stability Assays for Bioelectrodes for Biofuel Cells: Effect of Immobilization Matrix on Laccase Biocathode Stability
2014
Immunology of Tuberculosis
2001 Standout
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?
2006
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research
2007 Standout
Pulmonary Mycobacteriosis caused by Rifampicin-resistant Mycobacterium szulgai.
2000
Clinical review of pulmonary disease caused by Mycobacterium xenopi.
1983
High Current Density Air-Breathing Laccase Biocathode
2010
Activity of biocides against mycobacteria
1996
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
1996
O2Reduction in Enzymatic Biofuel Cells
2017
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Advanced Materials for Printed Wearable Electrochemical Devices: A Review
2016
Paratuberculosis
1994
Mycobacterium malmoense sp. nov.
1977
Activity of biocides against mycobacteria
1996
Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in south east England: a recent increase in the number of cases.
1995
Anion-exchange membranes in electrochemical energy systems
2014 Standout
Elektrochemie von Nanopartikeln
2014
Resistance ofBacillusEndospores to Extreme Terrestrial and Extraterrestrial Environments
2000 Standout
Multiple Imputation of Missing Values: Further Update of Ice, with an Emphasis on Categorical Variables
2009
The Immune Response in Tuberculosis
2013 Standout
Long-term Results of Pulmonary Resection for Atypical Mycobacterial Disease
1983
Mycobacterium avium complex infection in non‐cystic fibrosis bronchiectasis
2014
Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
1996
Genetic requirements for mycobacterial survival during infection
2003 Standout
Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?
2015
Bronchoscopic Microsampling for Bacterial Colony Counting in Relevant Lesions in Patients with Pulmonary Mycobacterium avium Complex Infection
2011
Infections due to non-tuberculous mycobacteria (NTM).
2004
Epidemiology of infection by nontuberculous mycobacteria
1996
Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s
2003
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Spectrum of Disease Due to Rapidly Growing Mycobacteria
1983
Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology
1990 Standout
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Multimerization of an Alcohol Dehydrogenase by Fusion to a Designed Self-Assembling Protein Results in Enhanced Bioelectrocatalytic Operational Stability
2019 StandoutNobel
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
The division between fast- and slow-growing species corresponds to natural relationships among the mycobacteria
1990
Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans
1996
Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals
1995
An integrated procedure for the extraction of bacterial isoprenoid quinones and polar lipids
1984 Standout
Clinical Characteristics and Treatment Outcomes ofMycobacterium kansasiiLung Disease in Korea
2010
The nature of mycobacterial disease in south east England, 1977-84.
1986
Long-term results of medical treatment in mycobacterium intracellulare infection
1979
Glutaraldehyde: Current Status and Uses
1994
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis.
1996
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
2012 Standout
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
The Continuing Challenges of Leprosy
2006 Standout
The Effect of Combined Therapy According to the Guidelines for the Treatment of Mycobacterium avium Complex Pulmonary Disease
2003
Self-Assembly of Colloidal Nanocrystals: From Intricate Structures to Functional Materials
2016 Standout
The Mycobacterium avium complex
1993
Lipids in Bacterial Taxonomy - A Taxonomist's View
1977
Evaluation of the efficacy of glutaraldehyde and peroxygen for disinfection of dental instruments
1998

Works of Peter Jenkins being referenced

How to Report Low-Level Laser Therapy (LLLT)/Photomedicine Dose and Beam Parameters in Clinical and Laboratory Studies
2011
Short course chemotherapy for tuberculosis of lymph nodes: a controlled trial. British Thoracic Society Research Committee.
1985
Pulmonary tuberculosis due to B.C.G.
1971
Infection with the Avian-Battey Group of Mycobacteria in England and Wales
1969
Antimycobacterial activity of ‘Virkon’
1993
Preliminary clinical evaluation of meningococcal disease and bacterial meningitis by ultrasonic enhancement
1998
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
2008
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment
2003
Isolation of Mycobacterium malmoense from the environment in Zaire
1995
Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy
2001
Evaluation of performance and stability of biocatalytic redox films constructed with different copper oxygenases and osmium-based redox polymers
2009
Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol
1995
Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
1992
Detection of meningitis antigens in buffer and body fluids by ultrasound-enhanced particle agglutination
1997
A mediated glucose/oxygen enzymatic fuel cell based on printed carbon inks containing aldose dehydrogenase and laccase as anode and cathode
2011
A comparison of glucose oxidase and aldose dehydrogenase as mediated anodes in printed glucose/oxygen enzymatic fuel cells using ABTS/laccase cathodes
2011
The opportunist mycobacteria—a 20-year retrospect
1971
Mycobacterium szulgai-a new pathogen. Serologic identification and report of five new cases.
1973
Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex.
1981
Lipid chromatography and seroagglutination in the classification of rapidly growing mycobacteria.
1971
Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
1987
Anti-mycobacterial activity of biocides
1991
Biocatalytic fuel cells: A comparison of surface pre-treatments for anchoring biocatalytic redox films on electrode surfaces
2008
Pulmonary infection with mycobacterium malmoense: A report of 4 cases
1985
The laboratory diagnosis of mycobacterial disease.
1992
Electroreduction of O2 at a mediated Melanocarpus albomyces laccase cathode in a physiological buffer
2008
Classification of Mycobacterium avium and related opportunist mycobacteria met in England and Wales
1967
Is HIV infection a risk factor for leprosy?
1991
Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.
1983
Citrate adsorption on Pt{hkl} electrodes and its role in the formation of shaped Pt nanoparticles
2012
Pulmonary infection with Mycobacterium gordonae in the presence of bronchial carcinoma
1985
Mycobacterium malmoense
1985
The Epidemiology of Opportunist Mycobacterial Infections in Wales, 1952-1978
1981
Thin-layer chromatography of mycobarcterial lipids as an aid to classification
1971
Pulmonary infection with mycobacterium xenopi: review of treatment and response.
1984
Pulmonary infection with mycobacterium malmoense—A review of treatment and response
1985
Diazonium salt derivatives of osmium bipyridine complexes: Electrochemical grafting and characterisation of modified surfaces
2010
Mycobacterium szulgai — A new pathogen
1972
Performance of a Glucose/O2 Enzymatic Biofuel Cell Containing a Mediated Melanocarpus albomyces Laccase Cathode in a Physiological Buffer
2008
Mycobacterial diseases
1981
Non-tuberculous mycobacterial lymphadenitis.
1986
Infections with Mycobacterium malmoense in England and Wales
1979
Lipid Analysis for the Identification of Mycobacteria: An Appraisal
1981
Mycobacterium malmoense in the North-east of England
1985
Rankless by CCL
2026